Form 4: Revvity Officer Exercises, Sells Shares Under 10b5-1 Plan

Revvity, Inc.'s Senior VP and Chief Commercial Officer, Victor Miriame, exercised stock options and sold the resulting shares as part of a pre-arranged 10b5-1 trading plan.

Summary

• Victor Miriame, Senior Vice President and Chief Commercial Officer of Revvity, Inc. (RVTY), engaged in a transaction involving company stock.
• On February 24, 2026, Miriame exercised 1,862 non-qualified stock options at an exercise price of $95.74 per share.
• Concurrently, Miriame sold 1,862 shares of Revvity common stock at a price of $97.13 per share.
• These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Miriame on November 26, 2025.
• Following these transactions, Miriame's direct beneficial ownership of common stock decreased from 19,984 shares to 18,122 shares, and the derivative securities (options) beneficially owned became 0.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It represents a routine, pre-planned monetization of vested equity by an executive, which is a common occurrence and does not signal a change in company fundamentals or outlook.

Positives

• The transaction demonstrates an officer monetizing vested equity, which is a common and expected part of executive compensation.
• The sale was conducted under a pre-arranged 10b5-1 trading plan, indicating a planned and transparent approach to insider trading, mitigating concerns about opportunistic selling.

Negatives

• The sale of shares by an officer, even under a 10b5-1 plan, reduces their direct equity stake in the company, which some investors might interpret as a slight reduction in alignment of interests, though this is a routine event.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are common across all industries as a mechanism for executives to manage their personal finances and diversify their holdings in a compliant manner. This transaction for Revvity's officer is consistent with standard practices in the life sciences and diagnostics sector.

Comparison to Industry Standards

• This type of transaction, involving the exercise of stock options and immediate sale of shares under a 10b5-1 plan, is a standard practice for executive compensation and personal financial management across publicly traded companies globally.
• Similar transactions are routinely reported by executives at peer companies like Danaher Corporation (DHR) or Thermo Fisher Scientific Inc. (TMO), where equity compensation forms a significant part of total remuneration.
• The execution under a pre-arranged plan aligns with best practices for transparency in insider dealings.

Related Party Transactions

• Victor Miriame, an officer of Revvity, Inc., engaged in the exercise of stock options and subsequent sale of common stock, which are considered related party transactions as they involve an insider of the company.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, pre-planned transaction by an officer. It may slightly reduce the officer's direct equity alignment but is not indicative of a change in company performance.
• Employees: No direct impact mentioned.
• Customers/Suppliers/Creditors: No direct impact mentioned.

Key Dates

Recommendation

The filing details a routine, pre-planned insider transaction (exercise of options and sale of shares under a 10b5-1 plan). Such transactions are common for executives managing their compensation and personal finances and typically do not provide new material information about the company's operational performance or future prospects that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this event alone does not alter the fundamental investment thesis for Revvity, Inc.

Keywords

Revvity, RVTY, Victor Miriame, Insider Trading, Form 4, Stock Option Exercise, Share Sale, 10b5-1 Plan, Officer Transaction, Equity Compensation